12.15 Lunch, Exhibition and Posters

13.15 - 16.35 Parallel Session 1: As-Live Surgery (with Surgeon Talk Through/Answering Questions)

(The Grand Ballroom)

Chairs: Ms Jean O’Riordain, Consultant Urological Surgeon, Bon Secour Hospital Cork, Ireland and Ms Naz Abbas Consultant Uro-Gynaecologist, Warrell Unit, St Mary's Hospital, Manchester NHS Foundation Trust. 

13.15  Introduction:  Ms Jean O’Riordain, Consultant Urological Surgeon, Bon Secour Hospital Cork, Ireland

13.20  Video 1: Ms Rachel Barratt, Consultant FRA Urological Surgeon. UCLH

14.00  Video 2: Annika Taithongchai, Consultant Obstetrician and Subspecialist in Urogynaecology, Kings College Hospital, London

 14.40 - 15.10 Tea Break, Exhibition and Posters

15.10  Video 3: Mr Jai Seth, Consultant Urological Surgeon, St George’s Hospital

15.50  Video 4: Mr Paul Moran Consultant Gynaecologist Worcester Hospital 

16.30  Conclusions: Ms Naz Abbas Consultant Uro-Gynaecologist, Warrell Unit, St Mary's Hospital, Manchester NHS Foundation Trust. 

12.15 Lunch, Exhibition and Posters

13.15 - 16.50 Parallel Session 2 Abstracts

(Balmoral Suite)

Chairs: Ms Angela Rantell, Urogynaecolgy Nurse Consultant, GSTK and Ms Angela Birnie Consultant FNUU Urologist, St Richards Hospital Chichester. 

Introduction: Dr Angela Rantell, Urogynaecolgy Nurse Consultant, King's College Hospital

Oral Podium Presentations

13.17 O1 A PROSPECTIVE 5 YEAR MULTICENTRE FOLLOW-UP STUDY OF THE EFFICACY OF A URETHRAL BULKING AGENT, CHOSEN BY WOMEN AS THEIR FIRST-LINE TREATMENT FOR STRESS URINARY INCONTINENCE IN THE UK

M. Bonilla, Manchester University Hospital

13.27 O2 FINDINGS FROM THE C-POP STUDY: EXPLORING THE ACCEPTABILITY AND FEASIBILITY OF A FUTURE RANDOMISED CONTROLLED TRIAL COMPARING TWO VAGINAL SURGERIES FOR THE TREATMENT OF APICAL PELVIC ORGAN PROLAPSE

L. Jones, The University of Birmingham

13.37 O3 ANTENATAL AND POSTNATAL SCREENING FOR PELVIC FLOOR DYSFUNCTION USING AN ELECTRONIC PATIENT REPORTED OUTCOME MEASURE (EPAQ-PELVIC FLOOR): SYMPTOM TRENDS AND IDENTIFICATION OF AFFECTED PATIENTS

T. Curtis, Ipswich Hospital

13.47 O4 EVALUATION OF PACEYCUFF AS A NOVEL TREATMENT FOR MALE STRESS URINARY INCONTINENCE: THE FIRST UK EXPERIENCE

C. Musabyimana, Royal Berkshire Hospital

13.57 O5 A SMALL SCALE STUDY TO EXPLORE THE PHYSICAL CHARACTERISTICS REQUIRED TO SELF MANAGE A PESSARY FOR PELVIC ORGAN PROLAPSE

C. Kotrie, Manchester Foundation Trust

14.07 O6 ABNORMALLY INVASIVE PLACENTA: A UROLOGICAL PERSPECTIVE

A. Awad, Norfolk and Norwich University Hospital

14.17 O7 STANDARD URODYNAMICS STUDIES: Does provocation matter?

E. Speck, Norfolk and Norwich University Hospital

1427 O8 ADHERENCE TO VAGINAL OESTROGENS IN PATIENTS IN A TERTIARY UROGYNAECOLOGY OUTPATIENT CLINIC

A. Waheed, King’s College Hospital

14.40 -15.10: Tea Break, Exhibition and Posters

Oral Poster Presentations

15.10 OP1 RENAL PAPILLARY HYPERTROPHY: A RARE CAUSE OF VISIBLE HAEMATURIA. A CASE REPORT

A. Al-Hajjaj, Chester

15.15 OP2 IS D-MANNOSE EFFECTIVE IN PREVENTION OF RECURRENT URINARY TRACT INFECTIONS?

A. Al-Hajjaj, Chester

15.20 OP3 PERCUTANEOUS TIBIAL NERVE STIMULATION(PTNS) FOR REFRACTORY OVERACTIVE BLADDER (OAB): ARE WE ABLE TO PREDICT THE LIKELIHOOD OF SUCCESS OF TREATMENT BASED ON EARLY RESPONSE?

A. Awad, Norfolk and Norwich University Hospital

15.25 OP4 A 5 YEAR OBSERVATIONAL STUDY OF THE MANAGEMENT OF MESH COMPLICATIONS IN A QUATERNARY MESH COMPLICATIONS SERVICE IN THE UK

H. Badri

15.30 OP5 AN OBSERVATIONAL STUDY OF PAIN OUTCOMES FOLLOWING SURGICAL AND NON-SURGICAL MANAGEMENT OF MESH ASSOCIATED PAIN SYNDROME (MAPS)

H. Badri

15.35 OP6 IS THERE STILL A ROLE FOR AMBULATORY UDA (AUDS)?

M. A. Batayneh, Birmingham Women’s Hospital

15.40 OP7 EVALUATING URETHRAL MICROTRAUMA: A COMPARISON OF HYDROPHILIC PVP-COATED AND IAS INTERMITTENT CATHETERS IN AN EX VIVO MODEL

J. Burns

15.45 OP8 DEEP LEARNING IMAGE-BASED CHARACTERISATION OF THE BLADDER IMMUNE RESPONSE IN CHRONIC URINARY TRACT INFECTION

C. Chieng, UCLH

15.50 OP9 REVIEW OF LEEDS SURGICAL OUTCOMESAND EXPERIENCE WITH vNOTES

M. Crouch, Leeds Teaching Hospital NHS Trust

15.55 OP10 YOU WANT TO LASER WHERE? OUCH, IS IT GOING TO HURT?

A.S. Da Silva, King’s College Hospital, London

16.00 OP11 A SISTERHOOD OF WOMEN- CO-CREATION OF RECOMMENDATIONS FOR IMPROVED PESSARY SELF-MANAGEMENT SUPPORT

L. Dwyer and S. Tibuzzi, Manchester NHS Foundation Trust

16.05 OP12 ‘A BEAUTIFUL LIFE AFTER PROLAPSE’-USING CREATIVE METHODS TO UNBOX THE IDENTITIES OF PESSARY USING WOMEN

L. Dwyer, Manchester NHS Foundation Trust

16.10 OP13 LIFELONG SURVEILLANCE OF THE NEUROGENIC BLADDER: Patient Satisfaction with a One Stop Uro-Neurology Clinic

A. Awad, Norfolk and Norwich University Hospital

16.15 OP14 MEDIUM TO LONG TERM OUTCOMES OF FEMALE VOBMG URETHROPLASTY

Azka Yousaf, UCLH

16.20 OP15 THE CHARACTERISTICS OF FEMALE URETHRAL STRICTURE

Vishali Sharma, UCLH

16.25 OP16 OUTCOMES OF RECTUS FASCIAL SLING FOR PRIMARY AND RECURRENT STRESS URINARY INCONTINENCE AND STRESS PREDOMINANT MIXED URINARY INCONTINENCE.

Keith Pace, UCLH

16.30 OP17 DOES MRI CONFIGURATION AFFECT THE LIKELIHOOD OF RECURRENCE FEMALE URETHRAL DIVERTICULUM FOLLOWING EXCISION UTILIZING A MODIFIED MARTIUS LABIAL FAT PAD INTERPOSITION.

Amna Butt, UCLH

16.35 OP18 EVALUATION OF WHETHER THE BENIGN COMPLEX UROLOGY MULTI-DISCIPLINARY TEAM (MDT) IS MEETING APPROPRIATE STANDARDS IN A SPECIALISED TERTIARY UNIT: FIRST CYCLE AUDIT

Amna Butt, UCLH

16.40 OP18A TOTAL LAPAROSCOPIC HYSTERECTOMY WITH BILATERAL UTEROSACRAL LIGAMENT PLICATION VERSUS VAGINAL HYSTERECTOMY, ANTERIOR REPAIR WITH MCCALL'S CULDOPLASTY FOR THE TREATMENT OF UTERINE PROLAPSE: A CASE-CONTROL STUDY WITH VIDEO DEMONSTRATION OF THE PROCEDURES

A. Bojang, Worcestershire Acute Hospitals NHS Trust

16.45  Conclusions: Ms Angela Birnie, Consultant FNUU Urologist, St Richards Hospital, Chichester.

12.15 Lunch, Exhibition and Posters

13.15 - 16.50 Parallel Session 3 Abstracts

(Dorset Suite)

Chairs: Ms Grace Chigodora, CNP FRA Urology UCLH and Ms Tamsin Greenwell, FRA Urology Consultant, UCLH

Introduction; Ms Grace Chigodora ,CNP FRA Urology, UCLH. 

Oral Podium Presentations

13.17 O9 A QUATERNARY MESH SERVICE EXPERIENCE OF ABDOMINALLY PLACED PROLAPSE MESH COMPLICATIONS AND EXCISION SURGERY

S. Singhal, University of Manchester

13.27 O10 IS IT MIRABEGRON OR VIBEGRON FOR OVERACTIVE BLADDER?

A. Al-Hajjaj, Chester

13.37 O11 IMPROVING ATTENDANCE RATES FOR VIDEOCYSTOMETROGRAPHY (VCMG): A CLOSED LOOP AUDIT

13.47 O12 IS ROBOTICS THE WAY FORWARD IN UROGYNAECOLOGY?

H. Preston, Liverpool Women’s Hospital

13.57 O13 MULTIDISCIPLINARY TEAM MEETING ROLE IN A TERTIARY SETTING

H. Mammadli, Nottingham University Hospitals NHS Trust

14.07 O14 DECEIVING VAGINAL LUMP : VAGINAL FIBROID PRESENTING AS A CYSTOCELE

E. Mohamed, Birmingham Women’s Hospital

14.17 O15 CHARACTERISTICS OF URINE AND URINE SEDIMENT IN POPULATIONS WITH LOWER URINARY TRACT DYSFUNCTION USING INTERMITTENT CATHETERISATION: A NON-INTERVENTIONAL CLINICAL STUDY

C. Pedersen, Coloplast

14.27 O16 THE ICS GLOBAL URODYNAMIC DATA REPOSITORY

A. Gammie, Bristol Urological Institute

14.40 -15.10  Tea Break, Exhibition and Posters

Oral Poster Presentations

15.10 OP19 CIRCUMCISIONS IN A PRIMARY CARE SETTING - OUTCOMES, BENEFITS AND ORGANISATIONAL POSSIBILITIES

Amos King

15.15 OP20 URINARY TRACT INFECTIONS: THE NEED FOR IMPROVED DIAGNOSTICS

Amos King

OP21 PRESENTATION WITHDRAWN

15.20 OP22 SPECIALIST CARE OF CHRONIC URINE INFECTIONS IN PREGNANCY LEADS TO GOOD PREGNANCY OUTCOMES

15.25 OP23 PELVIC FLOOR HEALTH AWARENESS AND PREVENTION OF PELVIC FLOOR DYSFUNCTION IN ANTENATAL WOMEN: SURVEY RESULTS

K. Y. Lor, King’s College Hospital

OP24 PRESENTATION WITHDRAWN

15.30 OP25 EARLY OUTCOMES IN WOMEN AFTER MESH REMOVAL SURGERY IN A SINGLE MESH CENTRE

A.M. Shetty, Belfast Health and Social Care Trust

15.35 OP26 POLYDIOXANONE (PDS) VS POLYPROPYLENE SUTURES IN COLPOSUSPENSION OR AUTOLOGOUS RECTUS FASCIAL SLING PROCEDURES FOR WOMEN WITH STRESS URINARY INCONTINENCE FOLLOWING MESH REMOVAL. A REVIEW OF PATIENT PREFERENCE

E. Oyekan, UCLH

15.40 OP27 IMPROVING PSYCHOSEXUAL PSYCHOTHERAPY OUTCOMES FOR MESH PATIENTS PRE AND POST SURGERY

C. Serridge, Saint Mary’s Hospital Manchester

15.45 OP28 REGIONAL MESH CLINIC REFERRALS SERVICE EVALUATION

L. Murtagh, Belfast Health and Social Care Trust

15.50 OP29 INTRODUCING RING PESSARY SELF-MANAGEMENT AS STANDARD CARE IN THE BELFAST TRUST

L. Murtagh, Belfast Health and Social Care Trust

15.55 OP30 CHALLENGES TO CHANGE - REFLECTIONS FROM A NEW NURSE-LED PESSARY SEL-MANAGEMENT CLINIC

L. Murtagh, Belfast Health and Social Care Trust

16.00 OP31 MANAGING GENITO-URINARY SYNDROME OF THE MENOPAUSE: UNDERSTANDING THE PATIENT JOURNEY

16.05 OP32 COMPARING THE SAFETY AND EFFICACY OF VIBEGRON, MIRABEGRON AND TOLTERODINE IN PATIENTS WITH OVERACTIVE BLADDER: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

16.10 OP33 A ONE-STOP RECURRENT UTIS CLINIC

F. Speck, Epsom & St Helier Hospital NHS Trust

16.15 OP34 AN AUDIT OF TREATMENT OUTCOMES FOR WET AND DRY OVERACTIVE BLADDER PATIENTS UNDERGOING PERCUTANEOUS TIBIAL NERVE STIMULATION

16.20 OP35 EXPLORING UK PRACTICES OF PERFORMING INTRAVESICAL BOTULINUM TOXIN A (BOTOX) FOR OVERACTIVE BLADDER

A. Waheed, King’s College Hospital

16.25 OP36 REVIEW OF POSTERIOR TIBIAL NERVE STIMULATION (PTNS) PRACTICE AT A NON-SPECIALIST NHS TRUST VIS À VIS THE EUROPEAN ASSOCIATION OF UROLOGY (EAU) AND NICE GUIDANCE

V. Antoniou, Royal Free Hospital

16.30 OP37 NO SLING IS TOO LOOSE: LESSONS TO BE LEARNT FROM COMPLICATIONS

E. Hart, Royal Free Hospital

16.35 Conclusions: Ms Tamsin Greenwell, FRA Urology Consultant, UCLH